Moreover, we highlighted the risky effects of plasma B7-H2 (or ICOS ligand) on rheumatoid arthritis (RA), as it has been validated in a mouse model of RA that anti-ICOS ligand domains can help reduce the disease symptoms [37]. Here, ICOS is linked to rheumatoid arthritis.